Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
The incidence of graft rejection and graft loss
at 1, 3, 6, 12, and 24 months
No
Sharon M Bartosh, MD
Study Chair
University of Wisconsin, Madison
United States: Food and Drug Administration
2003-0493
NCT00167661
June 2004
May 2014
Name | Location |
---|---|
University of Wisconsin Hospital and Clinics | Madison, Wisconsin 53792-0001 |